A Resource for Healthcare and Social Services Professionals
October 13, 2020
3:30 pm–5:00 pm ET
This webinar will provide an overview of federal privacy laws (including HIPAA and 42 CFR Part 2) as they relate to the provision of Medication for Opioid Use Disorder.
Via Zoom
Visit the meeting URL
Please note that space is limited for this event and that registration via Zoom is required.
The Center of Excellence for Protected Health Information (CoE-PHI) will host a 90 minute virtual presentation on October 13th from 3:30PM – 5:00PM EST that will provide an overview of federal privacy laws (including HIPAA and 42 CFR Part 2) as they relate to the provision of Medication for Opioid Use Disorder (MOUD). Recent amendments to 42 CFR Part 2, as well as changes likely forthcoming through the CARES Act in 2021 will also be discussed, with ample time built in for Q & A. In addition, participants will be introduced to resources and technical assistance available through the CoE-PHI.
Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Addiction Services
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.